Category Archives: Recent News

BriaCell Announces Advancement of its Small Molecule Program and Patent Allowance

BERKELEY, Calif. and VANCOUVER, British Columbia, November 13, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Provides Clinical Update

BERKELEY, Calif. and VANCOUVER, British Columbia, November 6, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

FDA Approves the Roll-Over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to their Immunotherapy in Patients with Advanced Breast Cancer

BERKELEY, Calif. and VANCOUVER, British Columbia, Oct 30, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Announces Warrant Incentive Program

Berkeley, CA and Vancouver, BC – October 13, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Repricing of Warrants

Berkeley, CA and Vancouver, BC – October 3, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Adds Third Clinical Site – Led by Top Physician-Scientist Dr. Lukas – To Expand Phase I/IIa Clinical Trial in Advanced Breast Cancer

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 25, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Provides Research Update

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 14, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Provides A Corporate Update

Berkeley, CA and Vancouver, BC – September 12, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Additional Capital Support by the CEO

Berkeley, CA and Vancouver, BC – Aug 2, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Top Oncologist and Opens Second Clinical Site for its Ongoing Clinical Trial in Advanced Breast Cancer

Berkeley, CA and Vancouver, BC – July 31, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...